Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Natural History of Skeletal Related Events in Patients with Multiple Myeloma Who Received First- and Second- Line Therapy with Novel Agents: Results from a Single Center Analysis in 620 Patients

Evangelos Terpos, MD PhD, Nikolaos Kanellias, MD, Eftathios Kastritis, Maria Gavriatopoulou, MD, Vassilis Koutoulidis, MD, Ioannis Ntanasis-Stathopoulos, MD, Aristea-Maria Papanota, MD, Despina Fotiou, MD, Magdalini Migkou, MD, Evangelos Eleutherakis-Papaiakovou, MD, Panagiotis Malandrakis, MD, Tina Bagratuni, PhD, Maria Roussou, MD, Lia A. Moulopoulos, MD, Meletios A. Dimopoulos, MD

Blood (2019) 134 (Supplement_1): 4326.

https://doi.org/10.1182/blood-2019-123606

Published: 2019

Journal Articles

No Decrease in Fracture Risk Despite 15 Years of Treatment Evolution in Multiple Myeloma Patients: A Danish Nationwide Case-Control Study

Berdien Oortgiesen, Annemariek Driessen, Mels Hoogendoorn, Dr., Robby Kibbelaar, Dr., Nic Veeger, Dr., Joop van der Bergh, Peter Vestergaard, Frank de Vries, Eric van Roon, Prof. Dr.

Blood (2019) 134 (Supplement_1): 5503.

https://doi.org/10.1182/blood-2019-122563

Published: 2019

Journal Articles

Risk of Fracture Following Front Line R-CHOP Immunochemotherapy in Older Patients with Diffuse Large B Cell Lymphoma Is Common

Stephen Booth, MA,MBBChir,MRCP,FRCPath, Hannah Plaschkes, Amy A Kirkwood, Adam Gibb, MBBS, Patrick Horgan, Joanna M Oladipo, Joseph Andrew Browning, DPhil,BMBCh, Usman Khan, John Willan, Julia Wolf, Arief Gunawan, MBBS, BSc, MRCP, Paul A Fields, MD PhD, Kim Linton, MBChB PhD, Claire Higham, Graham P. Collins, MA, MBBS, MRCP, FRCPath, DPhil, Jaimal Kothari, Catherine Hildyard, Toby A. Eyre

Blood (2019) 134 (Supplement_1): 1615.

https://doi.org/10.1182/blood-2019-127374

Published: 2019

Journal Articles

The Impact of Fractures on Survival in Multiple Myeloma: Results from a Population-Based Study

Sigrun Thorsteinsdottir, MD, Ingigerdur S Sverrisdottir, MD, Gauti Gislason, MSc, Ola Landgren, MD PhD, Ingemar Turesson, MD PhD, Magnus Björkholm, MD PhD, Sigurdur Y Kristinsson, MD PhD

Blood (2018) 132 (Supplement 1): 4490.

https://doi.org/10.1182/blood-2018-99-115403

Published: 2018

Journal Articles

Prevalence and Risk Factors of Low Bone Mineral Density and Fractures of Young Thalassemia Patients

Pokpong Piriyakhuntorn, MD, Adisak Tantiworawit, MD, Mattabhorn Phimphilai, MD, Somdet Srichairatanakool, Waralee Teeyasoontranon, MD, Thanawat Rattanathammethee, MD, Chatree Chai-Adisaksopha, MD, Ekarat Rattarittamrong, MD, Lalita Norasetthada, MD, Pimlak Charoenkwan, MD

Blood (2018) 132 (Supplement 1): 3636.

https://doi.org/10.1182/blood-2018-99-113465

Published: 2018

Journal Articles

Evidence Based Recommendations for Supportive Care in Multiple Myeloma

Anum Qureshi, Muhammad Junaid Tariq, MD, Zunairah Shah, MBBS, Muhammad Abu Zar, MD, Shehroz Aslam, MD, Abdul Rafae, MD, Mustafa Nadeem Malik, MD, Ahmad Kamal, MD, Jemin Aby Jose, MD, Insija Ilyas Selene, MBBS, Madeeha Shafqat, Faiza Jamil, MD, Seren Durer, MD, Ceren Durer, MD, Faiz Anwer, MD

Blood (2018) 132 (Supplement 1): 1952.

https://doi.org/10.1182/blood-2018-99-110748

Published: 2018

Journal Articles

Long Acting Zoledronic Acid Treatment for Vertebral Fracture Prevention in Multipl Myeloma Patients with Osteoporosis

Murat Cinarsoy, Ahmet Kursad Gunes, Hilmi Erdem Gozden

Blood (2018) 132 (Supplement 1): 1954.

https://doi.org/10.1182/blood-2018-99-111133

Published: 2018

Journal Articles

High Prevalence and Incidence of Fractures in Patients Treated for Aggressive B-Cell Non-Hodgkin Lymphomas

Li-Wen Huang, MD, Dong Sun, MD PhD, Weiyun Ai, MD PhD, Lawrence D Kaplan, MD, Thomas M Link, MD PhD, Thomas Lang, PhD, Charalambos Andreadis, MD MSCE

Blood (2017) 130 (Supplement 1): 4131.

https://doi.org/10.1182/blood.V130.Suppl_1.4131.4131

Published: 2017

Journal Articles

Functional and Pain Score Improvement with Vertebroplasty in De Novo Multiple Myeloma in a Public Institution in Mexico

Jorge Carlos Torres, Sr., Resident, Ramiro Espinoza, MD, Silvia Alarcon, Nidia Zapata, MD, Eduardo Cervera, Alejandro Sosa, Magnolia Vieyra, MD, Javier Espinoza, Luis Sosa, MD, Luis Oñate, Juan José Lahuerta, MD PhD, Manuel Aguilar, Resident

Blood (2016) 128 (22): 3324.

https://doi.org/10.1182/blood.V128.22.3324.3324

Published: 2016

Journal Articles

RANK-RANKL Mediated Bone Destruction in B-Cell Acute Lymphoblastic Leukemia

Sujeetha A. Rajakumar, MSc, Eniko Papp, PhD, Ildiko Grandal, MSc, Daniele Merico, PhD, Careesa C. Liu, MSc, Bedilu Allo, PhD, Lucia Zhang, Marc Grynpas, PhD, Mark D. Minden, MD PhD, Johann K. Hitzler, MD, Cynthia J. Guidos, PhD, Jayne S. Danska, PhD

Blood (2016) 128 (22): 908.

https://doi.org/10.1182/blood.V128.22.908.908

Published: 2016

Journal Articles

Efficacy and Safety of Four Factor Prothrombin Complex Concentrates As a Reversal Agent for Oral Xa Inhibitors

Krishna Gundabolu, MD, Brian Trevarrow, BA, Pharm.D., BCPS, Scott A Koepsell, MD, PhD, FCAP

Blood (2015) 126 (23): 4668.

https://doi.org/10.1182/blood.V126.23.4668.4668

Published: 2015

Journal Articles

Bone Mineral Density Utilization in Patients with Newly Diagnosed Multiple Myeloma: A Single Center Experience

Eli Muchtar, MD, Adi Zelig, Eyal Robenshtok, MD, Tzippy Shochat, MSc, Nino Oniashvili, PhD, Irina Amitai, MD, Pia Raanani, MD, Hila Magen, MD

Blood (2015) 126 (23): 5386.

https://doi.org/10.1182/blood.V126.23.5386.5386

Published: 2015

Journal Articles

A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis

Blood (2014) 124 (21): 3188.

https://doi.org/10.1182/blood.V124.21.3188.3188

Published: 2014

Journal Articles

Skeletal-Related Events In Myeloma: A Population-Based Study

John Ashcroft, MD, MBBChir, PhD, MRCP, MA, FRCPath, Bagguley Timothy, MSc, Alexandra Smith, PhD, Han-I Wang, PhD, Debra Howell, PhD, Hazem A Sayala, MBChB, MRCP, Gordon Cook, MD, PhD, Andrew Jack, PhD, Russell Patmore, MD, Eve Roman, PhD

Blood (2013) 122 (21): 3158.

https://doi.org/10.1182/blood.V122.21.3158.3158

Published: 2013

Journal Articles

Iron Status Independently Associates With Bone Mineral Density At Population Level. Insights From The Val Borbera Study

Nicola Martinelli, MD, PhD, Michela Traglia, Fabiana Busti, MD, Marcella Sirtori, MD, Natascia Campostrini, PhD, Cinzia Sala, PhD, Ginevra Biino, Corrado Masciullo, Michela Corbella, Daniele Manna, MD, Giorgio Pistis, Annalisa Castagna, PhD, Oliviero Olivieri, MD, Daniela Toniolo, PhD, Clara Camaschella, MD, Domenico Girelli, MD

Blood (2013) 122 (21): 4672.

https://doi.org/10.1182/blood.V122.21.4672.4672

Published: 2013

Journal Articles

Skeletal-Related Events In Patients With Multiple Myeloma In The Era Of Novel Agents: Low Incidence Of Pathological Fractures After Treatment

Evangelos Terpos, Nikolaos Kanellias, Lia A Moulopoulos, Dimitrios Christoulas, Andreas Koureas, Tina Bagratuni, Vasilios Koutoulidis, Efstathios Kastritis, Meletios A. Dimopoulos, MD

Blood (2013) 122 (21): 3090.

https://doi.org/10.1182/blood.V122.21.3090.3090

Published: 2013

Journal Articles

Vertebral Compression Fractures in Patients with Chronic Lymphocytic Leukemia: Incidence and Risk Factors

Amrita Desai, MD, MPH, Benjamin Kuritzky, MD, Jorge J Castillo, MD, Adam J. Olszewski, MD

Blood (2012) 120 (21): 4586.

https://doi.org/10.1182/blood.V120.21.4586.4586

Published: 2012

Journal Articles

The EOS ® System for the Detection of Bone Lesions in Patients with Multiple Myeloma,

Bastien Dutouquet, MD, Xavier Leleu, MD, PhD, Antoine Moraux, MD, Eileen Boyle, MD, Jordan Gauthier, MD, Houria Debarri, MD, Salomon Manier, MD, Marie Pierre Noel, MD, Thierry Facon, MD, Marie Helene Vieillard, MD, PhD, Anne Cotten, MD, Nathalie Boutry, MD, PhD

Blood (2011) 118 (21): 3921.

https://doi.org/10.1182/blood.V118.21.3921.3921

Published: 2011

Journal Articles

Exploring Vertebral Height Deficits in Patients with Thalassemia and Sickle Cell Disease,

Ellen B Fung, PhD, RD, CCD, Kathryn N Reget, Drucilla Haines, PNP, Aenor Sawyer, MD, Ashutosh Lal, MD

Blood (2011) 118 (21): 3198.

https://doi.org/10.1182/blood.V118.21.3198.3198

Published: 2011

Journal Articles

Long Term Efficacy of Percutaneous Vertebroplasty in Multiple Myeloma (MM) Patients: Experience of the “Gruppo Ematologico Di Romagna” (GER)

Patrizia Tosi, MD, Annalia Molinari, MD, Michele Sintini, MD, Anna Merli, MD, Michela Ceccolini, MD, Manuela Imola, MD, Paolo Savini, MD, Silvana Pasini, MD, Anna M Mianulli, MD, Barbara Castagnari, MD, Pier P Fattori, MD, Giovanni Martinelli, MD, PhD, Alfonso Zaccaria

Blood (2011) 118 (21): 5123.

https://doi.org/10.1182/blood.V118.21.5123.5123

Published: 2011

NARROW

Natural History of Skeletal Related Events in Patients with Multiple Myeloma Who Received First- and Second- Line Therapy with Novel Agents: Results from a Single Center Analysis in 620 Patients

No Decrease in Fracture Risk Despite 15 Years of Treatment Evolution in Multiple Myeloma Patients: A Danish Nationwide Case-Control Study

Risk of Fracture Following Front Line R-CHOP Immunochemotherapy in Older Patients with Diffuse Large B Cell Lymphoma Is Common

The Impact of Fractures on Survival in Multiple Myeloma: Results from a Population-Based Study

Prevalence and Risk Factors of Low Bone Mineral Density and Fractures of Young Thalassemia Patients

Evidence Based Recommendations for Supportive Care in Multiple Myeloma

Long Acting Zoledronic Acid Treatment for Vertebral Fracture Prevention in Multipl Myeloma Patients with Osteoporosis

High Prevalence and Incidence of Fractures in Patients Treated for Aggressive B-Cell Non-Hodgkin Lymphomas

Functional and Pain Score Improvement with Vertebroplasty in De Novo Multiple Myeloma in a Public Institution in Mexico

RANK-RANKL Mediated Bone Destruction in B-Cell Acute Lymphoblastic Leukemia

Efficacy and Safety of Four Factor Prothrombin Complex Concentrates As a Reversal Agent for Oral Xa Inhibitors

Bone Mineral Density Utilization in Patients with Newly Diagnosed Multiple Myeloma: A Single Center Experience

A Survey on Clinical and Biological Characteristic and Therapy Management of an Italian Series of 455 Adult Patients with Systemic Mastocytosis on Behalf of Italian Registry of Mastocytosis

Skeletal-Related Events In Myeloma: A Population-Based Study

Iron Status Independently Associates With Bone Mineral Density At Population Level. Insights From The Val Borbera Study

Skeletal-Related Events In Patients With Multiple Myeloma In The Era Of Novel Agents: Low Incidence Of Pathological Fractures After Treatment

Vertebral Compression Fractures in Patients with Chronic Lymphocytic Leukemia: Incidence and Risk Factors

The EOS ® System for the Detection of Bone Lesions in Patients with Multiple Myeloma,

Exploring Vertebral Height Deficits in Patients with Thalassemia and Sickle Cell Disease,

Long Term Efficacy of Percutaneous Vertebroplasty in Multiple Myeloma (MM) Patients: Experience of the “Gruppo Ematologico Di Romagna” (GER)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only